These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7787684)

  • 1. [The prediction of the individual chemosensitivity of human malignant tumors: the biological patterns and clinical results].
    Chissov VI; Sergeeva NS; Borisov VI; Skotnikova OI; Sviridova IK
    Eksp Klin Farmakol; 1995; 58(1):11-5. PubMed ID: 7787684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of antineoplastic chemotherapy based on the oncobiogram].
    Ebert A; Lenk H; Geyer J; Tanneberger S
    Arch Geschwulstforsch; 1989; 59(6):455-61. PubMed ID: 2596959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of chemosensitivity testing.
    Blumenthal RD
    Methods Mol Med; 2005; 110():3-18. PubMed ID: 15901922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cultures and their use in drug sensitivity prediction.
    Dendy PP; Mitchell JS; Dawson A; Williamson J
    Arch Geschwulstforsch; 1981; 51(1):111-8. PubMed ID: 7259433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New anticancer agents: in vitro and in vivo evaluation.
    Zips D; Thames HD; Baumann M
    In Vivo; 2005; 19(1):1-7. PubMed ID: 15796152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
    O'Meara AT; Sevin BU
    Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay.
    Hunter EM; Sutherland LA; Cree IA; Dewar JA; Preece PE; Wood RA; Linder D; Andreotti PE
    Eur J Surg Oncol; 1993 Jun; 19(3):242-9. PubMed ID: 8314382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCA-100 tumour chemosensitivity assay: differences in sensitivity between cultured tumour cell lines and clinical studies.
    Andreotti PE; Linder D; Hartmann DM; Cree IA; Pazzagli M; Bruckner HW
    J Biolumin Chemilumin; 1994; 9(6):373-8. PubMed ID: 7879653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting cancer drug response by proteomic profiling.
    Ma Y; Ding Z; Qian Y; Shi X; Castranova V; Harner EJ; Guo L
    Clin Cancer Res; 2006 Aug; 12(15):4583-9. PubMed ID: 16899605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].
    Tian HM; Shi XY; Fu J; Chao DY; Zhang K; Wu LY; Wang JW; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):296-8. PubMed ID: 15996325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro drug resistance versus chemosensitivity: two sides of different coins.
    Fruehauf JP; Alberts DS
    J Clin Oncol; 2005 May; 23(15):3641-3; author reply 3646-8. PubMed ID: 15908686
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemosensitivity test on brain tumors].
    Gil-Salú JL; Bosco-López J; Domi Nguez-Villar M; Domínguez-Pascual I; Pérez-Requena J; Palomo MJ; López-Escobar M
    Neurocirugia (Astur); 2008 Feb; 19(1):5-11. PubMed ID: 18335150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemosensitivity prediction in tumor cells ex vivo--difficulties and limitations of the method].
    Michalová E; Poprach A; Nemecková I; Nenutil R; Valík D; Zaloudík J; Vyzula R; Vojtesek B
    Klin Onkol; 2008; 21(3):93-7. PubMed ID: 19097417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Approaches to the individual prognosis of tumor reaction to radiation and drug exposures].
    Dar'ialova SL; Pelevina II; Saenko AS
    Med Radiol (Mosk); 1990 Jan; 35(1):10-4. PubMed ID: 2308493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reversal of drug resistance and prediction of the response to cytostatics. Experimental drug therapy for tumors has clinical potential].
    Larsson R; Nygren P; Bergh J
    Lakartidningen; 1991 Dec; 88(51-52):4441-4. PubMed ID: 1774991
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemosensitivity testing and the drug resistance of human tumors].
    Ludwig C
    Dtsch Med Wochenschr; 1989 Sep; 114(36):1375-9. PubMed ID: 2673717
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro testing of chemosensitivity in physiological hypoxia.
    Grigoryan R; Keshelava N; Anderson C; Reynolds CP
    Methods Mol Med; 2005; 110():87-100. PubMed ID: 15901930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
    Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T
    Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems in chemosensitivity testing].
    Kondo T
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):592-8. PubMed ID: 7717708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical guidelines for diagnostic use of in vitro chemosensitivity tests.
    Schinköthe T; Haeger S; Gabri MR
    Anticancer Res; 2007; 27(3A):1365-7. PubMed ID: 17593632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.